{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:42:03Z","timestamp":1772005323901,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":41,"publisher":"Springer New York","isbn-type":[{"value":"9781493986446","type":"print"},{"value":"9781493986453","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-8645-3_13","type":"book-chapter","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T09:43:19Z","timestamp":1536313399000},"page":"197-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Serpins in Venous Thrombosis and Venous Thrombus Resolution"],"prefix":"10.1007","author":[{"given":"Subhradip","family":"Mukhopadhyay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tierra A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajabrata","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni M.","family":"Antalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,8]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1160\/TH10-03-0183","volume":"104","author":"S Deroo","year":"2010","unstructured":"Deroo S, Deatrick KB, Henke PK (2010) The vessel wall: a forgotten player in post thrombotic syndrome. Thromb Haemost 104:681\u2013692","journal-title":"Thromb Haemost"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/ATVBAHA.110.213405","volume":"31","author":"P Saha","year":"2011","unstructured":"Saha P, Humphries J, Modarai B et al (2011) Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. Arterioscler Thromb Vasc Biol 31:506\u2013512","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/ATVBAHA.112.251983","volume":"32","author":"CM Ripplinger","year":"2012","unstructured":"Ripplinger CM, Kessinger CW, Li C et al (2012) Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging. Arterioscler Thromb Vasc Biol 32:2616\u20132624","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/ATVBAHA.108.163097","volume":"28","author":"S Moll","year":"2008","unstructured":"Moll S, Mackman N (2008) Venous thromboembolism: a need for more public awareness and research into mechanisms. Arterioscler Thromb Vasc Biol 28:367\u2013369","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jvs.2010.08.050","volume":"53","author":"PK Henke","year":"2011","unstructured":"Henke PK, Comerota AJ (2011) An update on etiology, prevention, and therapy of postthrombotic syndrome. J Vasc Surg 53:500\u2013509","journal-title":"J Vasc Surg"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1258\/phleb.2010.010018","volume":"25","author":"PK Henke","year":"2010","unstructured":"Henke PK, Pannucci CJ (2010) Venous thromboembolism risk factor assessment and prophylaxis. Phlebology 25:219\u2013223","journal-title":"Phlebology"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0741-5214(98)70057-6","volume":"28","author":"MH Meissner","year":"1998","unstructured":"Meissner MH, Caps MT, Zierler BK et al (1998) Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 28:826\u2013833","journal-title":"J Vasc Surg"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1160\/TH06-11-0669","volume":"97","author":"BR Binder","year":"2007","unstructured":"Binder BR, Mihaly J, Prager GW (2007) uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost 97:336\u2013342","journal-title":"Thromb Haemost"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","volume":"25","author":"A Mondino","year":"2004","unstructured":"Mondino A, Blasi F (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 25:450\u2013455","journal-title":"Trends Immunol"},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1182\/blood.V86.11.4007.bloodjournal86114007","volume":"86","author":"EK Kruithof","year":"1995","unstructured":"Kruithof EK, Baker MS, Bunn CL (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86:4007\u20134024","journal-title":"Blood"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1084\/jem.187.11.1799","volume":"187","author":"TM Antalis","year":"1998","unstructured":"Antalis TM, La Linn M, Donnan K et al (1998) The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha\/beta priming. J Exp Med 187:1799\u20131811","journal-title":"J Exp Med"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"27894","DOI":"10.1074\/jbc.270.46.27894","volume":"270","author":"JL Dickinson","year":"1995","unstructured":"Dickinson JL, Bates EJ, Ferrante A et al (1995) Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem 270:27894\u201327904","journal-title":"J Biol Chem"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1365-3024.2010.01241.x","volume":"32","author":"WA Schroder","year":"2010","unstructured":"Schroder WA, Gardner J, Le TT et al (2010) SerpinB2 deficiency modulates Th1Th2 responses after schistosome infection. Parasite Immunol 32:764\u2013768","journal-title":"Parasite Immunol"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.4049\/jimmunol.0902187","volume":"184","author":"WA Schroder","year":"2010","unstructured":"Schroder WA, Le TT, Major L et al (2010) A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity. J Immunol 184:2663\u20132670","journal-title":"J Immunol"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"31348","DOI":"10.1074\/jbc.M604220200","volume":"281","author":"GA Darnell","year":"2006","unstructured":"Darnell GA, Schroder WA, Gardner J et\u00a0al (2006) SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication. J Biol Chem 281:31348\u201331358","journal-title":"J Biol Chem"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1073\/pnas.96.2.686","volume":"96","author":"KM Dougherty","year":"1999","unstructured":"Dougherty KM, Pearson JM, Yang AY et al (1999) The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. Proc Natl Acad Sci U S A 96:686\u2013691","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1161\/01.CIR.0000050149.22928.39","volume":"107","author":"I Singh","year":"2003","unstructured":"Singh I, Burnand KG, Collins M et al (2003) Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation 107:869\u2013875","journal-title":"Circulation"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0741-5214(95)70041-2","volume":"22","author":"AD Northeast","year":"1995","unstructured":"Northeast AD, Soo KS, Bobrow LG et al (1995) The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. J Vasc Surg 22:573\u2013579","journal-title":"J Vasc Surg"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jvs.2006.07.020","volume":"44","author":"JA Gossage","year":"2006","unstructured":"Gossage JA, Humphries J, Modarai B et al (2006) Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution. J Vasc Surg 44:1085\u20131090","journal-title":"J Vasc Surg"},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/bmj.290.6480.1453","volume":"290","author":"IM Nilsson","year":"1985","unstructured":"Nilsson IM, Ljungner H, Tengborn L (1985) Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J (Clin Res Ed) 290:1453\u20131456","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"Suppl 4","key":"13_CR21","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S0049-3848(09)70141-0","volume":"123","author":"TW Wakefield","year":"2009","unstructured":"Wakefield TW, Myers DD, Henke PK (2009) Role of selectins and fibrinolysis in VTE. Thromb Res 123(Suppl 4):S35\u2013S40","journal-title":"Thromb Res"},{"key":"13_CR22","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/jth.12657","volume":"12","author":"SA Siefert","year":"2014","unstructured":"Siefert SA, Chabasse C, Mukhopadhyay S et al (2014) Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice. J Thromb Haemost 12:1706\u20131716","journal-title":"J Thromb Haemost"},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jvs.2012.02.054","volume":"56","author":"JF Baldwin","year":"2012","unstructured":"Baldwin JF, Sood V, Elfline MA et al (2012) The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis. J Vasc Surg 56:1089\u20131097","journal-title":"J Vasc Surg"},{"key":"13_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jvsv.2012.10.015","volume":"1","author":"AT Obi","year":"2013","unstructured":"Obi AT, Diaz JA, Farris DM et al (2013) Vitronectin gene-deletion, PAI-1 gene-deletion, and LMWH treatment: effect on thrombus resolution and vein wall remodeling in a mouse model of DVT. J Vasc Surg Venous Lymphat Disord 1:103","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/jth.12644","volume":"12","author":"AT Obi","year":"2014","unstructured":"Obi AT, Diaz JA, Ballard-Lipka NL et al (2014) Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism. J Thromb Haemost 12:1353\u20131363","journal-title":"J Thromb Haemost"},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/jth.12704","volume":"12","author":"EE Gardiner","year":"2014","unstructured":"Gardiner EE, Medcalf RL (2014) Is plasminogen activator inhibitor type 2 really a plasminogen activator inhibitor after all? J Thromb Haemost 12:1703\u20131705","journal-title":"J Thromb Haemost"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1172\/JCI60229","volume":"122","author":"N Mackman","year":"2012","unstructured":"Mackman N (2012) New insights into the mechanisms of venous thrombosis. J Clin Invest 122:2331\u20132336","journal-title":"J Clin Invest"},{"key":"13_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139145","volume":"10","author":"KP Nguyen","year":"2015","unstructured":"Nguyen KP, McGilvray KC, Puttlitz CM et al (2015) Matrix metalloproteinase 9 (MMP-9) regulates vein wall biomechanics in murine thrombus resolution. PLoS One 10:e0139145","journal-title":"PLoS One"},{"key":"13_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jvsv.2014.03.001","volume":"3","author":"C Chabasse","year":"2015","unstructured":"Chabasse C, Siefert SA, Chaudry M et al (2015) Recanalization and flow regulate venous thrombus resolution and matrix metalloproteinase expression in vivo. J Vasc Surg Venous Lymphat Disord 3:64\u201374","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jth.12424","volume":"12","author":"J Gabre","year":"2014","unstructured":"Gabre J, Chabasse C, Cao C et al (2014) Activated protein C accelerates venous thrombus resolution through heme oxygenase-1 induction. J Thromb Haemost 12:93\u2013102","journal-title":"J Thromb Haemost"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0037-1613739","volume":"92","author":"SM Day","year":"2004","unstructured":"Day SM, Reeve JL, Myers DD et al (2004) Murine thrombosis models. Thromb Haemost 92:486\u2013494","journal-title":"Thromb Haemost"},{"key":"13_CR32","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/ATVBAHA.111.244608","volume":"32","author":"JA Diaz","year":"2012","unstructured":"Diaz JA, Obi AT, Myers DD et al (2012) Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol 32:556\u2013562","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"13_CR33","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1182\/blood-2016-07-727180","volume":"129","author":"S Mukhopadhyay","year":"2017","unstructured":"Mukhopadhyay S, Antalis TM, Nguyen KP et al (2017) Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice. Blood 129:3245\u20133255","journal-title":"Blood"},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1001\/archinte.1993.00410240085010","volume":"153","author":"A Cogo","year":"1993","unstructured":"Cogo A, Lensing AW, Prandoni P et al (1993) Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Arch Intern Med 153:2777\u20132780","journal-title":"Arch Intern Med"},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML Bruhl von","year":"2012","unstructured":"von Bruhl ML, Stark K, Steinhart A et al (2012) Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209:819\u2013835","journal-title":"J Exp Med"},{"key":"13_CR36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/CH-131680","volume":"56","author":"M Brandt","year":"2014","unstructured":"Brandt M, Schonfelder T, Schwenk M et al (2014) Deep vein thrombus formation induced by flow reduction in mice is determined by venous side branches. Clin Hemorheol Microcirc 56:145\u2013152","journal-title":"Clin Hemorheol Microcirc"},{"key":"13_CR37","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1182\/blood-2010-05-287623","volume":"117","author":"A Brill","year":"2011","unstructured":"Brill A, Fuchs TA, Chauhan AK et al (2011) von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 117:1400\u20131407","journal-title":"Blood"},{"key":"13_CR38","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1161\/ATVBAHA.112.252130","volume":"32","author":"A Brill","year":"2012","unstructured":"Brill A, Yesilaltay A, De Meyer SF et al (2012) Extrahepatic high-density lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice. Arterioscler Thromb Vasc Biol 32:1841\u20131847","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"13_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/ATVBAHA.110.216317","volume":"31","author":"PK Henke","year":"2011","unstructured":"Henke PK, Mitsuya M, Luke CE et al (2011) Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution. Arterioscler Thromb Vasc Biol 31:43\u201349","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"13_CR40","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1172\/JCI40782","volume":"121","author":"M Nosaka","year":"2011","unstructured":"Nosaka M, Ishida Y, Kimura A et al (2011) Absence of IFN-gamma accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice. J Clin Invest 121:2911\u20132920","journal-title":"J Clin Invest"},{"key":"13_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/jth.12510","volume":"12","author":"J Geddings","year":"2014","unstructured":"Geddings J, Aleman MM, Wolberg A et al (2014) Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH. J Thromb Haemost 12:571\u2013573","journal-title":"J Thromb Haemost"}],"container-title":["Methods in Molecular Biology","Serpins"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8645-3_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T05:02:19Z","timestamp":1604898139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8645-3_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493986446","9781493986453"],"references-count":41,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8645-3_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}